Clinical Evaluation of Lyral® Dose Response Study
NCT02028182
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Contact Dermatitis
Interventions
BIOLOGICAL:
Lyral®
Sponsor
Allerderm